The Ozempic Effect: How GLP-1 Drugs Are Reshaping Retail Stocks
Millions are losing weight on GLP-1s and refreshing their wardrobes. Wall Street is only beginning to price what this means for retail stocks.
Millions are losing weight on GLP-1s and refreshing their wardrobes. Wall Street is only beginning to price what this means for retail stocks.
The Iran war proved drones are decisive in modern combat. Pentagon contracts are accelerating — here are the defense stocks analysts are watching in 2026.
S&P 500 mega-cap concentration is backfiring in 2026. Equal-weight ETFs like RSP are quietly outperforming. Here’s what that means for investors.
Brent crude topped $120 as the US-Iran ceasefire shows cracks. What a sustained oil shock means for inflation, Fed rate cuts, and global markets.
When tariff policy can reverse overnight, S&P 500 valuation becomes guesswork. Here’s how Wall Street is trying — and failing — to price it in.
The “Sell in May and Go Away” pattern is real but imperfect. Here is what six decades of S&P 500 data, academic research, and 2026 market conditions actually reveal.
Delta, Carnival, and European airlines jumped as much as 7% on the Iran ceasefire. Here’s why travel stocks lead geopolitical relief rallies — and what risks remain.
Morgan Stanley and Fundstrat are calling for surprise beats as Q1 2026 earnings season kicks off. Here’s why analysts think the chaos may actually help.
SK Hynix surged 15%, TSMC 4.8%, Tokyo Electron 10% on ceasefire news. The hidden driver: Iran had been strangling the chip industry’s helium supply.
Wall Street traders have a new acronym for Trump’s pattern of dramatic threats followed by sudden retreats — and it’s reshaping how markets price geopolitical risk in 2026.